Stroke subtypes and outcomes in China,common clinical conundrums in stroke management,and pediatric stroke

Abstract

Keywords

Stroke global China stroke subtypes oral anticoagulant atrial fibrillation intracerebral hemorrhage seizures pediatric

Get full access to this article

View all access options for this article.

References

Markus

Leung

Stroke in China. Int J Stroke 2023; 18: 256–258.

Chun

Qin

Turnbull

, et al. Heterogeneity in the diagnosis and prognosis of ischemic stroke subtypes: 9-year follow-up of 22,000 cases in Chinese adults. Int J Stroke 2023; 18: 847–855.

Zhao

Hua

Ren

, et al. Increasing burden of stroke in China: a systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality. Int J Stroke 2022; 18: 259–267.

Chen

Wang

, et al. The quality disparity of stroke care over time: an analysis based on the national dataset from 2011 to 2017. Int J Stroke 2022; 18: 304–311.

Wang

Zhang

, et al. Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: analyses of a nationwide serial cross-sectional survey from 2005 to 2015. Int J Stroke 2023; 18: 821–828.

Xie

Fang

, et al. Effect of the Shanghai Stroke Service System (4S) on the quality of stroke care and outcomes: a prospective quality improvement project. Int J Stroke 2023; 18: 599–606.

Lam

BYK

Cai

Akinyemi

, et al. The global burden of cerebral small vessel disease in low- and middle-income countries: a systematic review and meta-analysis. Int J Stroke 2023; 18: 15–27.

Alrohimi

Rose

Burgin

, et al. Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: a pooled analysis of prospective studies and randomized trials. Int J Stroke 2023; 18: 864–872.

Fischer

Koga

Strbian

, et al. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med 2023; 388: 2411–2421.

10.

King

Lawrence

Milling

Warach

SJ.

Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke 2019; 14: 977–982.

11.

Best

Arram

Ahmed

, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke 2022; 17: 583–589.

12.

Kim

Lee

Yoon

, et al. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis. Int J Stroke 2023; 18: 812–820.

13.

Mota Telles

Rocha

Cenci

Nager

Silva

Figueiredo

EG.

Prophylactic antiseizure drugs for spontaneous intracerebral hemorrhage: an updated systematic review and meta-analysis. Int J Stroke 2022; 18: 773–782.

14.

Greenberg

Ziai

Cordonnier

, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2022; 53: e282–e361.

15.

Feigin

Brainin

Norrving

, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 2022; 17: 18–29.

16.

Gao

Lim

Nguyen

, et al. The incidence of pediatric ischemic stroke: a systematic review and meta-analysis. Int J Stroke 2023; 18: 765–772.